FIELD: medicine, neurosurgery.
SUBSTANCE: the present innovation deals with treating cerebral lesions of different etiology. Into common carotid artery it is necessary to inject autologous stem cells isolated from bone marrow - mononuclears at the quantity of 1-5 x 108 cells. Therapeutic course includes twice thrice injection at an interval of 1-2 d. The innovation enables to shorten therapy terms due to accelerated clinical effect, neurological rehabilitation and prevent allergic and other unfavorable reaction of therapy conducted.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INTRODUCING FOR TREATING INFLAMMATORY BRAIN DISEASE CASES | 2005 |
|
RU2286154C2 |
METHOD OF TREATING SUPRATENTORIAL GLIAL BRAIN GROWTHS | 2013 |
|
RU2533032C1 |
METHOD OF TREATING INFANTILE CEREBRAL PARALYSIS | 2008 |
|
RU2385746C1 |
METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
METHOD OF TREATING LOWER EXTREMITY ISCHEMIA | 2012 |
|
RU2546007C2 |
BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
METHOD FOR TREATMENT OF BRAIN CONFUSION | 2007 |
|
RU2347578C1 |
METHOD FOR SELECTING NEUROONCOLOGICAL PATIENTS FOR IMMUNOTHERAPY | 2005 |
|
RU2297632C2 |
DIAGNOSTIC TECHNIQUE FOR CHRONIC LATENT CHLAMIDIA INFECTIONS IN CENTRAL NERVOUS SYSTEM | 2008 |
|
RU2361217C1 |
Authors
Dates
2007-02-20—Published
2004-11-17—Filed